Arhaus

Arhaus

ARHS· Retail Trade· Fiscal year ends in December

CEO pay in FY2025Stock +19.3% in FY2025

John Reed is the CEO of Arhaus and was paid $4.6M in FY2025 (Dec), up 106%.

Pay$100 in the stock at the end of FY21 → $85
CEO pay is from each Arhaus proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives8

See all
  1. 1Lisa ChiFY2025
  2. 2Jennifer PorterFY2025
  3. 3John ReedFY2025
  4. 4Michael LeeFY2025
  5. 5Kathy VeltriFY2025
  6. 6Allison SutleyFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Arhaus paid its 8 named executives $25.4M in total in FY2025 (Dec). CEO John Reed was paid $4.6M of that.

Name
Lisa ChiFormer Chief Merchandising Officer
Jennifer PorterChief Marketing and eCommerce OfficerNot disclosed
John ReedPresident and Chief Executive Officer
Michael LeeChief Financial OfficerNot disclosedNot disclosed
Kathy VeltriChief Retail Officer
Allison SutleyChief Information OfficerNot disclosedNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers17

See all

The FY2025 (Dec) proxy of Arhaus names 17 peer companies for pay. Among Arhaus and these peers, CEO pay was 7th highest of 9 and total shareholder return was 6th highest of 9.

7th highest of 9in Arhaus and its pay peers, FY2025 (Dec) by CEO pay:

$1.3M$45.9M

6th highest of 9in Arhaus and its pay peers, FY2025 (Dec) by total shareholder return:

$42$780

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Activity

  1. PayDEF 14A
  2. PayDEF 14A
  3. PayDEF 14A
  4. PayDEF 14A
  5. PayDEF 14A
  6. PayDEF 14A
  7. PayDEF 14A
  8. PayDEF 14A
  9. PayDEF 14A
  10. PayDEF 14A
  11. PayDEF 14A

Filings6

See all
Proxy statementDEF 14AApr 2, 2026FY2025
Annual report10-KFeb 26, 2026FY2025
Proxy statementDEF 14AApr 10, 2025FY2024
Annual report10-KFeb 26, 2025FY2024
Proxy statementDEF 14AMar 28, 2024FY2023
Annual report10-KMar 11, 2024FY2023